Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 93
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?

    Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant bacteria...

    Are Emergency Doctors Uncomfortable Treating Patients in Psychiatric Crisis? If so, Why?

    This survey research study aims to explore the amount of confidence emergency physicians have with treating...

    Can albumin from egg whites be used to treat Clostridium difficile infections?

    Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections and...

    Backer Badge Funded